Auravax Therapeutics

Biotechnology Research • United States • 1-10 Employees

Company overview

Headquarters	United States
Website	auravax.com
NAICS	541714
Founded	2020
Employees	1-10
Socials

Key Contacts at Auravax Therapeutics

Tom Finn

Member, Board Of Directors, Auravax Therapeutics

Joseph Sullivan

Chief Executive Officer

Auravax Therapeutics Email Formats

Auravax Therapeutics uses 1 email format. The most common is {first initial}{last name} (e.g., jdoe@auravax.com), used 100% of the time.

Format	Example	Percentage
{first initial}{last name}	jdoe@auravax.com	100%

About Auravax Therapeutics

AuraVax Therapeutics, Inc. is a privately held biopharmaceutical company developing NanoSTING for the treatment and prevention of upper respiratory disease due to all major viral pathogens. This platform activates the STING pathway to trigger an effective innate immune response upon intranasal delivery. We are developing NanoSTING for global access to address the disease burden of current respiratory viruses and future emerging pathogens.

Auravax Therapeutics revenue & valuation

Annual revenue	$598,885
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$2,000,000
Total funding	$253,200

Employees by Management Level

Total employees: 1-10

Seniority

Employees

C-Suite

Director

Employees by Department

Auravax Therapeutics has 2 employees across 2 departments.

Departments

Number of employees

Funding Data

Explore Auravax Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2025-10-15	9	$253,200

Funding Insights

$253,200

Total funding amount

$253,200

Most recent funding amount

Number of funding rounds

Auravax Therapeutics Tech Stack

Discover the technologies and tools that power Auravax Therapeutics's digital infrastructure, from frameworks to analytics platforms.

reCAPTCHA

Security

ElementsKit

WordPress plugins

Slick

JavaScript libraries

Swiper

JavaScript libraries

Hello Elementor

WordPress themes

Elementor

Page builders

jQuery Migrate

JavaScript libraries

jQuery

JavaScript libraries

PHP

Programming languages

WordPress

Blogs

Yoast SEO

SEO

Google Workspace

Frequently asked questions

Auravax Therapeutics is located in US.

Auravax Therapeutics was founded in 2020, making it 6 years old. The company has established itself as a significant player in its industry over this time.

Auravax Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Auravax Therapeutics has raised a total of $253,200 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contacts at Auravax Therapeutics

Tom Finn

Member, Board Of Directors, Auravax Therapeutics

Joseph Sullivan

Chief Executive Officer

4.8

40,000 users